CN1219514C - 具有高吸收性的口服制剂 - Google Patents
具有高吸收性的口服制剂 Download PDFInfo
- Publication number
- CN1219514C CN1219514C CNB021439834A CN02143983A CN1219514C CN 1219514 C CN1219514 C CN 1219514C CN B021439834 A CNB021439834 A CN B021439834A CN 02143983 A CN02143983 A CN 02143983A CN 1219514 C CN1219514 C CN 1219514C
- Authority
- CN
- China
- Prior art keywords
- vitamin
- agent
- tocopherol
- present
- bisbenzamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP313977/2001 | 2001-10-11 | ||
| JP2001313977A JP2003119141A (ja) | 2001-10-11 | 2001-10-11 | 吸収性を向上した経口投与製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1411812A CN1411812A (zh) | 2003-04-23 |
| CN1219514C true CN1219514C (zh) | 2005-09-21 |
Family
ID=19132362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021439834A Expired - Fee Related CN1219514C (zh) | 2001-10-11 | 2002-09-29 | 具有高吸收性的口服制剂 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2003119141A (https=) |
| KR (1) | KR20030030882A (https=) |
| CN (1) | CN1219514C (https=) |
| TW (1) | TWI244921B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4780907B2 (ja) * | 2003-09-30 | 2011-09-28 | 小林製薬株式会社 | 催眠剤組成物 |
| JP4721631B2 (ja) * | 2003-09-30 | 2011-07-13 | 小林製薬株式会社 | 催眠剤組成物 |
| JP5094899B2 (ja) * | 2010-03-23 | 2012-12-12 | 小林製薬株式会社 | 催眠剤組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61151132A (ja) * | 1984-12-24 | 1986-07-09 | Kanebo Ltd | ビタミンk↓2経口剤の製造法 |
| JPS63310827A (ja) * | 1987-06-15 | 1988-12-19 | Sanwa Kagaku Kenkyusho Co Ltd | ニコチン酸誘導体を主剤とする徐放性製剤 |
| JPH10130171A (ja) * | 1996-09-04 | 1998-05-19 | Dot:Kk | 経口投与用医薬組成物 |
| US6197328B1 (en) * | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
-
2001
- 2001-10-11 JP JP2001313977A patent/JP2003119141A/ja active Pending
-
2002
- 2002-09-05 TW TW091120354A patent/TWI244921B/zh not_active IP Right Cessation
- 2002-09-29 CN CNB021439834A patent/CN1219514C/zh not_active Expired - Fee Related
- 2002-10-07 KR KR1020020060903A patent/KR20030030882A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HK1054695A1 (en) | 2003-12-12 |
| JP2003119141A (ja) | 2003-04-23 |
| TWI244921B (en) | 2005-12-11 |
| CN1411812A (zh) | 2003-04-23 |
| KR20030030882A (ko) | 2003-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2716948C (en) | Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients | |
| JP5626890B2 (ja) | リポ酸のペレット組成物 | |
| TW202025997A (zh) | 正常化胺基酸代謝的方法 | |
| DE69935326T2 (de) | Zusammensetzungen enthaltend molybden zur steigerung des proteinanabolismus und der entgiftung | |
| JP5114399B2 (ja) | 疲労予防及び/又は回復のための医薬 | |
| US20190151275A1 (en) | Composition for treatment of neurodegenerative disease | |
| CN1219514C (zh) | 具有高吸收性的口服制剂 | |
| JPH10287560A (ja) | 医薬組成物 | |
| CN100467038C (zh) | 一种含多种维生素的护肝制剂的生物学药理学作用及其制备方法 | |
| US20090247496A1 (en) | Pharmaceutical composition and extract of poria for enhancing uptake of nutrients | |
| WO2022196943A2 (ko) | 코엔자임 큐텐 함유 액상 보조사료 조성물 | |
| CN109602893A (zh) | 一种改善肝损伤及机体疲劳的组合物及其制剂 | |
| JPH03204814A (ja) | 腎不全用経口アミノ酸製剤 | |
| US20210128466A1 (en) | Reduced volume formulations including amino acid entities | |
| JPH07330593A (ja) | 疲労改善剤 | |
| HK1054695B (en) | Oral administration preparation improved in absorbability | |
| JP5114394B2 (ja) | 疲労回復のための医薬 | |
| JP2011068647A (ja) | アスパラギン酸又はその塩含有固形製剤 | |
| Soni et al. | Simultaneous determination of vitamins B1, B2 and B6 in multivitamin tablet and biological fluid by RP-HPLC | |
| CN1244326C (zh) | 抗疲劳药物组合物 | |
| WO2023220103A1 (en) | Dietary supplement compositions | |
| JP2022170992A (ja) | 生薬等含有液状組成物 | |
| KR20230065181A (ko) | 티아민 또는 그의 유도체와 피돌산 마그네슘을 포함하는 경구용 조성물 및 복합 제제 | |
| JP5533949B2 (ja) | 疲労改善内服剤 | |
| JPH06247876A (ja) | アルコール性肝障害軽減剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050921 Termination date: 20100929 |